Preliminary results suggest anti-COVID19 nanobodies may be effective at preventing and diagnosing infections.

According to researchers, antibodies against seasonal coronaviruses are not able to protect against severe COVID-19 infection.

Researchers have determined 3D shapes of eight neutralizing antibodies attached to SARS-CoV-2.

The rate of COVID-19 transmission is unaffected by the arrival of spring or summer.

Researchers have formulated a model to show that the viral loads in infected people and the rate of viral spread in the population have a correlation and these viral loads can be used to measure the spread rates.

During severe COVID-19 infection, the human immune system instigates an excessive inflammatory response.

IIT Kharagpur study has led to the formulation of a set of environmental recommendations for solid waste management under the pandemic situation.

Scientists are searching for a number that can represent the level of severity in COVID-19 infected patients.

The researchers observed that more than 10% of the severely infected people with COVID-19 had autoantibodies that targeted the type-1 interferon activity.

Scientists studied the response of 40 people aged 56 and above to the vaccine developed by the Cambridge based biotechnology firm Moderna.